← FDA DRUG APPROVALS

FDA ANDA · ANDA065004

CYCLOSPORINE

Sponsor: HIKMA

APPLICATION
ANDA065004
TYPE
ANDA
ORIGINAL APPROVAL
1999-10-29
LATEST ACTION
2010-10-18
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

CYCLOSPORINEPrescription
CYCLOSPORINE 50MG/ML · INJECTABLE · INJECTION

Approval history

2010-10-18Labeling · Supplement 8AP
2010-09-23Labeling · Supplement 7AP
2002-04-30Labeling · Supplement 1AP
2001-04-03Manufacturing (CMC) · Supplement 2AP
1999-10-29OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →